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Re: Evaluating Gastric Cancer
Misclassification: a Potential
Explanation for the Rise in
Cardia Cancer Incidence
Increased incidence of adenocarci-
noma of the gastric cardia has been re-
ported over the last few decades from
several areas of North America and Eu-
rope (1–2). A mortality study from the
Swedish Cancer Registry, however, sug-
gested that the observed upward trends
can be, partly or largely, accounted for
by changed accuracy of registration
within gastric subsites (3).
We considered, therefore, trends in
incidence rates for various gastric sub-
sites in the Cancer Registry of the Swiss
Canton of Vaud (covering approxi-
mately 600 000 inhabitants in 1990
from the French-speaking part of Swit-
zerland) over the period from 1976
through 1997. In this area, uniform cri-
teria of classification have been adopted,
and traditional attention has been fo-
cused on careful endoscopic and histo-
pathologic examination of gastric le-
sions (4–6).
Table 1 gives average age-adjusted
(on the world standard population)
incidence rates for various subsites of
gastric cancer during three separate cal-
endar periods. In both sexes, no
appreciable change in incidence of
adenocarcinoma of the gastric cardia
was observed (3.1 cases per 100 000
males, and 0.5 cases per 100 000 fe-
males from 1976 through 1979 versus
3.2 and 0.1, respectively, from 1995
through 1997), while appreciable
downward trends were observed for dis-
tal and other or unspecified gastric can-
cer sites.
These data, from a carefully surveyed
European population, therefore do not
support the existence of a systematic
and major rise in incidence of cardiac
adenocarcinomas (3,7), confirming
that—in proportional terms—the can-
cers of the gastric cardia have become
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more frequent because of the decline of
distal (and unspecified) gastric cancers.
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RESPONSE
We appreciate the timely test of our
hypothesis performed by Dr. Levi and
colleagues. Their data seem to confirm
that when tumor misclassification is
kept at a minimum, there is virtually no
increase in the incidence of cardiac ad-
enocarcinomas. We will elaborate on the
secular trends of cardiac and noncardiac
gastric adenocarcinoma in Sweden in a
separate paper, but we can reveal that
we have made the same observation as
Dr. Levi and his co-workers. It remains
to be clarified whether the absence of a
true upward trend is limited to northern
and central Europe or whether all the
worldwide increases can be attributed to
misclassification.
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Table 1. Trends in age adjusted incidence rates of gastric carcinomas according to sex and subsite
from Vaud, Switzerland, 1976–1997
Subsite Sex*
Incidence rate (No. of cases)†
Annual
change (%)‡1976–1979 1985–1989 1995–1997
Cardia M 3.1 (47) 2.8 (59) 3.2 (41) −0.4
F 0.5 (11) 0.5 (16) 0.1 (4) −5.6
Distal M 6.1 (90) 5.8 (124) 2.7 (42) −3.9
F 3.2 (68) 2.0 (68) 1.7 (37) −2.9
Subsite, other and unspecified M 3.9 (60) 2.1 (45) 2.4 (35) −3.6
F 2.0 (45) 1.0 (29) 0.5 (12) −5.7
Total carcinomas, all subsites M 13.1 (197) 10.8 (228) 8.4 (118) −2.7
F 5.7 (124) 3.5 (113) 2.3 (53) −3.9
*M 4 male; F 4 female.
†Age-adjusted rates on the world population, per 100 000 population per year.
‡Average annual percentage change in a log-linear model.
1586 CORRESPONDENCE Journal of the National Cancer Institute, Vol. 91, No. 18, September 15, 1999
